RecruitingOBSERVATIONAL

French Childhood Cancer Survivor Study

The 'French Childhood Cancer Survivor Study' is looking into the long-term effects of childhood solid tumours and their treatments. It aims to understand health issues, like new cancers or heart problems, and social challenges that might come up years after treatment. By tracking thousands of people treated for cancer as children in France, researchers hope to identify who might be at higher risk for certain problems. This knowledge will help improve follow-up care and develop better ways to prevent these issues. The study is following these survivors for up to 20 years, gathering information from their medical records, official registries, and questionnaires about their lives.

At a glance

Status

Recruiting

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Enrolment target

18,000

Start

01 Nov 2011

Estimated completion

01 Nov 2031

Childhood Solid Tumor

What is this study about?

The French Childhood Cancer Survivor Study (FCCSS) is a large, important research project. Its main goal is to understand how having a solid tumour as a child and receiving specific treatments, like radiotherapy or chemotherapy, might affect health and life many years later. For example, some treatments can increase the risk of developing another cancer or heart problems later on. The researchers also want to see how these experiences impact everyday life, such as education, jobs, and overall well-being.

By carefully studying thousands of people treated for childhood cancer in France before the year 2000, the FCCSS aims to figure out which treatments or doses might lead to particular long-term problems. This information is vital because it helps doctors and nurses understand which survivors might need special follow-up care. The study collects detailed information from medical records, national health databases, and questionnaires filled out by the survivors themselves to paint a complete picture.

Learning more about these long-term effects means we can better support childhood cancer survivors. It helps develop new guidelines for health checks and care that are specifically designed for them. Ultimately, the study hopes to improve the quality of life for everyone who has had cancer as a child by preventing unwanted side effects and ensuring they get the best possible care for many years to come.

Key takeaways

This study helps improve long-term care for childhood cancer survivors.
It looks at health and social effects many years after treatment.
Data comes from existing medical records and questionnaires, not new treatments.
It covers people treated for solid tumours in France before 2000.
Information gathered helps doctors understand risks and prevent future problems.

Who may be eligible?

This study is looking for people who were diagnosed with a solid tumour (not leukaemia) in France before their 19th birthday. You would have needed to have been diagnosed between 1942 and 1999. It's important that your full identification details, such as your full name and date and place of birth, are clearly recorded so the researchers can track your health records.

Essentially, if you had a solid cancer as a child or teenager in France during those years and your details are known, you might be part of this study. The study doesn't include people who had leukaemia, which is a different type of cancer affecting blood cells, as their health challenges are often different.

If you believe you or a family member fits these descriptions, your past treatment centre or French health authorities might have more information about whether you are included in this research.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

I was diagnosed with a solid tumour, not leukaemia.
My cancer was diagnosed before my 19th birthday.
My diagnosis happened between 1942 and 1999.
I received treatment for cancer in France.
My full identification details are likely recorded in medical history.

Answer every question to see your result.

What does participation involve?

This study is gathering information from existing records and questionnaires rather than directly involving patients in new treatments or regular hospital visits. Researchers will collect details from your past medical records about your original cancer and treatments, including the doses of radiotherapy and chemotherapy you received. They will also look at official national registries for information about your health status and, if applicable, causes of death.

You may be asked to complete a questionnaire about your life after cancer treatment. This could cover things like your social situation, family, whether you have children, how you access healthcare, your job, and financial matters. Additionally, information from your national health insurance system might be used to understand your healthcare expenses. The study will follow its participants for up to 20 years, starting from 2011, by collecting these types of data over time.

Potential risks and benefits

Participating in this study primarily involves researchers looking at your existing health information, which generally carries very low risk to you personally. There are no new treatments or procedures involved. The main benefit is that your health information contributes to important research that will help improve care and understanding for all childhood cancer survivors in the future, identifying potential risks and helping to prevent them. All information is kept confidential. You have the right to withdraw your consent for your data to be used at any time without affecting your medical care.

Locations (36)

Centre Hospital-Universitaire Hôpital Nord
Verified postcode
Amiens, France· Active not recruiting
Centre Hospitalier-Universitaire
Verified postcode
Angers, France· Active not recruiting
Centre Hospitalier Régional Universitaire Hôpital Saint-Jacques
Verified postcode
Besançon, France· Active not recruiting
Groupe hospitalier Pellegrin
Verified postcode
Bordeaux, France· Active not recruiting
Centre Hospitalier Universaitaire Hôpital Côte de Nacre
Verified postcode
Caen, France· Active not recruiting
Centre Hospitalier Universitaire Hôpial Hôtel Dieu
Verified postcode
Clermont-Ferrand, France· Active not recruiting
Centre Hospitalier Universaitaire hôpital d'enfants
Verified postcode
Dijon, France· Active not recruiting
Hôpital La Tronche
Verified postcode
Grenoble, France· Active not recruiting
Centre Oscar Lambret
Verified postcode
Lille, France· Active not recruiting
Hôpital Jeanne De Flandre
Verified postcode
Lille, France· Active not recruiting
Hôpital de la mère et de l'enfant
Verified postcode
Limoges, France· Active not recruiting
Institut d'Hématologie et Oncologie Pédiatrique
Verified postcode
Lyon, France· Active not recruiting

Common questions

What kind of childhood cancer are you studying?

We are focusing on 'solid tumours,' which are cancers that form a lump, rather than blood cancers like leukaemia.

Why is this study important for people like me?

Understanding the long-term effects of childhood cancer helps us improve follow-up care and prevent health and social problems for all survivors. Your information helps make this possible.

Will I have to take any new medicines or visit the hospital?

No, this study only uses existing medical records and questionnaires; there are no new medicines, treatments, or hospital visits involved.

How long will my information be used for?

The study aims to follow participants for up to 20 years from 2011, using your information during that period.

How will my personal information be kept safe?

All personal information collected for the study is kept confidential and handled securely to protect your privacy.

How to find out more

Florent F. de Vathaire, Ph.D

florent.devathaire@igr.fr Official trial record

Always speak to your GP or specialist before deciding to take part in a study.